我要投票 上海医药在化学药物行业中的票数:278
· 外 推 电 报 ·
2025-05-07 04:13:15 星期三

【上海医药是哪个国家的品牌?】

上海医药是什么牌子?「上海医药」是 上海医药集团股份有限公司 旗下著名品牌。该品牌发源于上海市,由创始人周军在1994-01-18期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力上海医药品牌出海!将品牌入驻外推网,定制上海医药品牌推广信息,可以显著提高上海医药产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

上海医药集团股份有限公司是中国唯一一家在医药产品和分销市场方面均居领先地位的医药上市公司,公司研发以创新为长期坚持的方向,致力于为重大疾病和慢性病提供安全有效的治疗药物,2012年研发投入占公司制药业务销售收入4.72%。公司建立了以中央研究院为技术核心的集团总院分院研发体系,拥有1个国家级企业技术中心以及10个省市级企业技术中心,入选十余项“重大新药创制”国家科技重大专项。公司采用开放式研究模式,与中国科学院上海药物所建立了创新药物研发战略联盟,与中国药科大学、沈阳药科大学等建立联合实验室,与日本三菱田边制药株式会社、上海复旦张江生物医药等合作开展创新药物研发;同时,还通过项目引进、合作开发等方法开始进入治疗性抗体领域。

上海医药制造覆盖化学和生物药品、现代中药和保健品、医疗器械等领域,产品聚焦心脑血管类、全身性抗感染类、消化系统和免疫代谢类、神经精神类、抗肿瘤类五大治疗领域,生产片剂、胶囊、粉针(含冻干)、小容量注射液、滴眼剂、气雾剂、凝胶剂等20种以上剂型,过亿产品20个。公司旗下的信谊、雷氏、龙虎、青春宝、胡庆余堂、苍松、国风、神象等多个品牌为中国驰名商标。公司药品生产严格执行中国新版GMP要求,有多个原料药或制剂通过了WHO、FDA、欧盟以及其他发达国家的质量认证。

上海医药的分销网络以中国经济最发达的华东、华北、华南三大重点区域为中心辐射全国各地,业务规模排名全国第二。公司分销业务以医院纯销为主,并与全球40多家跨国药企开展合作。公司的疫苗、高端耗材、DTP(高值药品直送)及SPD(医药物流管理技术)等新业务发展在国内处于领先地位。公司分销服务正逐步走向以供应链延伸服务和临床支持服务为核心的医院现代服务解决方案,为医院客户提供终端解决方案、专项物流和信息化服务。

上海医药零售拥有华氏、雷允上、余天成、人寿天、雷蒙、科园信海大药房等诸多知名品牌,覆盖全国12个省、直辖市及自治区,门店总数1792家。2012年公司药品零售销售规模居全国药品零售行业前五位,上海华氏大药房为华东地区拥有药房最多的企业。上海医药的零售业务包括连锁药店、合办药房、DTP药房等多种业态,并积极发展电子商务实现网上销售。

上海医药倡导“创新、诚信、合作、包容、责任”的企业核心价值观,致力于持之以恒,提升民众的健康生活品质,努力打造受人尊敬、拥有行业美誉度的领先品牌药制造商和健康领域服务商。



英文翻译:Shanghai Pharmaceutical Group Co., Ltd. is the only pharmaceutical listed company in China that has a leading position in both pharmaceutical products and distribution market. The company's R & D takes innovation as the long-term direction and is committed to providing safe and effective treatment drugs for major diseases and chronic diseases. In 2012, the R & D investment accounted for 4.72% of the company's pharmaceutical business sales revenue. The company has established a R & D system with the Central Research Institute as the technical core of the group's General Institute and branch, with 1 national enterprise technology center and 10 provincial and municipal enterprise technology centers, and has been selected into more than 10 national science and technology major projects of "major new drug creation". The company adopts an open research mode, establishes a strategic alliance for innovative drug research and development with Shanghai Institute of pharmaceutical science, Chinese Academy of Sciences, a joint laboratory with China Pharmaceutical University, Shenyang Pharmaceutical University, etc., and carries out innovative drug research and development in cooperation with Japan Mitsubishi taganabe Pharmaceutical Co., Ltd., Shanghai Fudan Zhangjiang biomedical Co., Ltd.; at the same time, it also starts through project introduction, cooperative development and other methods Enter the field of therapeutic antibody. Shanghai pharmaceutical manufacturing covers chemical and biological medicine, modern Chinese medicine and health products, medical devices and other fields, products focus on cardiovascular, systemic anti infection, digestive system and immune metabolism, neuropsychiatric, anti-tumor five treatment areas, producing tablets, gels, powder injection (including freeze-dried), small volume injection, eye drops, aerosol, gel and so on 20 kinds. More than 20 over 100 million products. Xinyi, Leishi, Longhu, qingqingyutang, Cangsong, Guofeng, Shenxiang and other brands under the company are well-known trademarks in China. The company strictly implements the new GMP requirements in China, and several APIs or preparations have passed the quality certification of who, FDA, EU and other developed countries. Shanghai Pharmaceutical's distribution network centers on the three key regions of East China, North China and South China, which are the most developed regions in China. Its business scale ranks the second in China. The company's distribution business is mainly hospital pure sales, and cooperates with more than 40 multinational pharmaceutical companies around the world. The company's vaccine, high-end consumables, DTP (direct delivery of high-value drugs) and SPD (pharmaceutical logistics management technology) and other new business development are in a leading position in China. The company's distribution service is gradually moving towards a modern hospital service solution with the core of supply chain extension service and clinical support service, providing terminal solutions, special logistics and information services for hospital customers. Shanghai Pharmaceutical retail has many famous brands such as Huashi pharmacy, leiyunshang pharmacy, yutiancheng pharmacy, lifetian pharmacy, Leimeng pharmacy, Keyuan Xinhai pharmacy, covering 12 provinces, municipalities and autonomous regions, with a total number of 1792 stores. In 2012, the company's drug retail sales scale ranked the top five in the national drug retail industry, and Shanghai Huashi pharmacy is the enterprise with the largest number of pharmacies in East China. Shanghai Pharmaceutical's retail business includes chain drugstores, joint drugstores, DTP drugstores and other formats, and actively develops e-commerce to achieve online sales. Shanghai Pharmaceutical advocates the core values of "innovation, integrity, cooperation, inclusiveness and responsibility". It is committed to persevere, improve people's healthy life quality, and strive to build a respected leading brand drug manufacturer and health service provider with industry reputation.

本文链接: https://www.waitui.com/brand/9b09c6ba1.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美国3月贸易逆差创新高

美国3月贸易逆差1405亿美元,预估为逆差1372亿美元,前值为逆差1227亿美元。(界面)

14分钟前

尚美数智:五一假期期间累计满房数量达到6011次,同比增长21.9%

36氪获悉,尚美数智酒店集团数据显示,五一假期期间累计满房数量达到6011次,同比增长21.9%,入住率(OCC)同比增长7.2%,其中雷神电竞酒店、尚客优悦和品睿酒店入住率增长明显。从每间可售房收入(RevPAR)来看,尚美数智酒店集团旗下酒店整体RevPAR同比提升15.1%。其中尚客优、尚客优悦和品睿分别同比增长14%、14%和19%,在假期市场中展现出强劲吸引力。

14分钟前

金力泰:因未在法定期限内披露2024年年度报告被证监会立案

36氪获悉,金力泰公告,公司于2025年5月6日收到中国证券监督管理委员会下发的《立案告知书》,因公司未在法定期限内披露2024年年度报告,中国证监会决定对公司立案。立案调查期间,公司将积极配合相关调查工作,并持续关注该事项后续进展。公司表示,上述事项不会对公司的正常生产经营活动产生影响。

14分钟前

美股大型科技股盘前普跌,特斯拉跌超1%

36氪获悉,美股大型科技股盘前普跌,截至发稿,特斯拉、谷歌、英伟达、Meta、亚马逊跌超1%,微软跌0.64%,苹果跌0.57%,奈飞跌0.44%。

14分钟前

热门中概股美股盘前涨跌不一,小马智行涨近10%

36氪获悉,热门中概股美股盘前涨跌不一,截至发稿,蔚来、小鹏汽车、爱奇艺跌超1%,网易跌0.53%;阿里巴巴涨超2%,百度涨超1%,拼多多涨0.72%,京东涨0.68%;与Uber达成战略合作,小马智行涨近10%。

14分钟前

本页详细列出关于上海医药的品牌信息,含品牌所属公司介绍,上海医药所处行业的品牌地位及优势。
咨询